Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis

Cytokine

Volumn 57, Issue 1, 2012, Pages 46-53

  Bandapalli, Obul R ^a   Ehrmann, Franziska ^a   Ehemann, Volker ^a   Gaida, Matthias ^a   Macher Goeppinger, Stephan ^a   Wente, Moritz ^a   Schirmacher, Peter ^a   Brand, Karsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chemokines; Colorectal liver metastasis; CXCL1; Nude mouse

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL1; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; UP-REGULATION;

MUS MUSCULUS;

EID: 84155172374     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.10.019     Document Type: Article

References (30)

1. Becker N., Wahrendorf J. Krebsatlas der Bundesrepublik Deutschland 1997, Springer, Berlin, Heidelberg, New York.
2. Grem J.L. Current treatment approaches in colorectal cancer. Semin Oncol 1991, 18 1(Suppl 1):17-26.
3. Bandapalli O.R., et al. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 2006, 118(1):74-89.
4. Bandapalli O.R., et al. Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens. BMC Genomics 2008, 9:448.
5. Brand K., et al. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 2000, 60(20):5723-5730.
6. Gerg M., et al. Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Mol Cancer Res 2008, 6(3):341-351.
7. Kahlert C, et al. (2008) Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 28 (3A): 1459-65.
8. Kopitz C., et al. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 2007, 67(18):8615-8623.
9. Bandapalli O.R., et al. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases. J Pathol 2009, 218(3):370-379.
10. Opdenakker G., Van Damme J. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. Int J Dev Biol 2004, 48(5-6):519-527.
11. Strieter R.M., et al. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006, 42(6):768-778.
12. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008, 267(2):226-244.
13. Keeley E.C., Mehrad B., Strieter R.M. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010, 106:91-111.
14. Luan J., et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997, 62(5):588-597.
15. Wang D., Richmond A. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway. J Biol Chem 2001, 276(5):3650-3659.
16. Wilson C., et al. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. J Pharmacol Exp Ther 2008, 327(3):746-759.
17. Xia M., Hyman B.T. GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation - a role in Alzheimer's disease?. J Neuroimmunol 2002, 122(1-2):55-64.
18. Li A., Varney M.L., Singh R.K. Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin Exp Metastasis 2004, 21(7):571-579.
19. Doll D., et al. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int J Colorectal Dis 2010, 25(5):573-581.
20. Wen Y., et al. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res 2006, 12(20 Pt 1):5951-5959.
21. Baier P.K., et al. Chemokines in human colorectal carcinoma. Anticancer Res 2005, 25(5):3581-3584.
22. Erreni M., et al. Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol 2009, 460:105-121.
23. Chiu S.T., et al. Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(2):437-443.
24. Zhou Y., et al. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells. Carcinogenesis 2005, 26(12):2058-2068.
25. Moore B.B., et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999, 154(5):1503-1512.
26. Dhawan P., Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 2002, 72(1):9-18.
27. Yang J., et al. Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res 2001, 61(22):8150-8157.
28. Kawanishi H., et al. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 2008, 14(9):2579-2587.
29. Elezkurtaj S., et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis. J Gene Med 2004, 6(11):1228-1237.
30. Wang D., et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 2006, 203(4):941-951.